1. Mims Drugs Prescription
2. Mims Book

MIMS Featured Media Type Value Period ABC 2,013 ABC 3,063 Claimed print 2,000 2011-05-01 Claimed circulation 4,000 2019-01-01 ABC 5,232 Extra.: mobiMIMS for smartphones and tablets available. Refer website.: eMIMS available. Refer website. Additional print opportunity: various directories published ad hoc. On application.: MIMS South Africa website. Key Updates.

2018-10-20 New periodical titles 4xpa directory featuring generic medicine information. 2011-05-16 New periodical titles (Avusa Media: MIMS Div.). Target Medical doctors, hospitals and clinics, dentists, pharmacists, nursing sisters, medical aids, dispensing doctors, healthcare providers. Subscription cost Total delivery Print order Print ABC Certificate: Business to Business Start Date 2018-07-01 End Date 2018-09-30 Cover Price TOTAL CIRCULATION CORE CIRCULATION TOTAL SALES Sales: Subscriptions Business Sales: Single Copy Sales Sales: Other TOTAL FREE Free: Controlled Distributions Individual Requested Free: Other Digital Total Verification Period Mailed Download Online Read. Effective Status Rate type Currency VAT% Comm.% Original% Change Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Standard rates ZAR 0.00 16.500 Rate Change Legend: Size / Calculation change No increase Increase Decrease.

Complementary medicines listed in MIMS a commonly used electronic reference used by health professionals are being misleadingly represented as if they have been assessed by health authorities, an expert claims. Dr Ken Harvey, adjunct senior lecturer at the school of public health at Melbourne's La Trobe University, said doctors might not realise that information on listed complementary medicines in MIMS was provided by the products' manufacturers, and received no independent validation. This information was 'potentially erroneous and harmful', he told Australian Doctor. MIMS disclaimers currently state that product information has been provided by pharmaceutical companies and is 'approved by the Therapeutic Goods Administration'. However, Dr Harvey said this disclaimer did not accurately reflect the difference between prescription products, which underwent a detailed assessment before TGA approval, and listed complementary medicines, which were not routinely checked by the TGA. Dr Harvey said MIMS should be required to disclose that information on complementary products has 'not been independently assessed by Australian health authorities'. He raised the concerns after finding some health websites were promoting a complementary product known as Urinary Tract Support, using information sourced from eMIMS, under the impression it had been validated.

• GMT mims drug guide pdf - The Monthly Index of Medical Specialities or MIMS is a pharmaceutical prescribing reference guide published in the United Kingdom since 1959 by Haymarket Media Group.The guide contains information about branded and generic drugs in the UK formulary. The print title is.
• Entire MIMS Manual (pdf) manualv1-22.pdf: 4.46 MB: Printer-friendly version.

His complaint follows a government brief released earlier this month, which revealed that 90% of complementary medicines subjected to post-market reviews by the TGA were found to be non-compliant with regulatory requirements. Just 26% of newly listed complementary medicines were subject to review last year, according to the document, which was released under freedom of information laws and marked 'in-confidence'. MIMS declined to comment at the time of writing.

Mims Drugs Prescription

Mims Book

The Monthly Index of Medical Specialities or MIMS is a pharmaceutical prescribing reference guide published in the United Kingdom since 1959 by Haymarket Media Group. The guide contains information about branded and generic drugs in the UK formulary.